Emitents | Olainfarm, AS (213800WCG52W62ENOP27) |
Veids | Citi |
Valoda | EN |
Statuss | Publicēts |
Versija | |
Datums | 2013-12-10 15:58:04 |
Versijas komentārs | |
Teksts |
Olainfarm
will Hold Third Quarter 2013 Investor Conference
Webinar
AS
„Olainfarm” invites shareholders, investors, mass media
representatives and other stakeholders to join its second quarter
2013 investor conference webinar scheduled on December 10, 2013
at 16:00 (EET). Webinar
will be hosted by the member of the management board Salvis Lapiņš.
The presentation will be in English. During the
webinar topics in relation to AS “Olainfarm” latest activities and
analysis of third quarter 2013 financial results will be discussed.
After the
presentation investors will be welcomed to ask
questions. Due to the limited webinar time, please send
in your questions in advance till December 9 to e-mail:
ieva.kadakovska@nasdaqomx.com.
What is
webinar?
How to
join the webinar? Additional
information on the webinar The
enclosed presentation will be presented during the
webinar.
A/s OlainFarm is one of the biggest pharmaceutical companies in
Latvia with 40 years of experience in production of medication and
chemical and pharmaceutical products. A basic principle of
company's operations is to produce reliable and effective top
quality products for Latvia and the rest of the world. Products
made by the Group are being exported to more than 30 countries of
the world, including the Baltics, Russia, other CIS, Europe, Asia,
North America and Australia. Information
prepared by: |
Pielikumi |